Gabapentin Lawsuit Attorneys

A dementia or memory-loss diagnosis is frightening enough without also wondering whether a medication you trusted played a role. That's not something you should have to figure out on your own. It's what we're here for. If you or a family member used gabapentin or Lyrica long-term for something like back pain, migraines, anxiety, or fibromyalgia, and were later diagnosed with dementia, mild cognitive impairment, or unexplained memory loss, we want to hear from you. Call us any time, day or night, for a free, no-obligation case review.

Call 412-394-1000 for a free gabapentin lawsuit case review. There is never a fee unless we get money for you.

What Is Gabapentin?

Gabapentin is a nerve medication sold under brand names including Neurontin, Gralise, and Horizant, and prescribed to millions of Americans every year. Neurontin is FDA-approved to treat epilepsy and postherpetic neuralgia, the nerve pain that follows shingles. Gralise and Horizant carry their own narrower FDA-approved uses. But gabapentin, in all its forms, is also one of the most widely prescribed off-label drugs in the country, routinely given for chronic back pain, migraines, anxiety, fibromyalgia, and restless leg syndrome, conditions the FDA never evaluated it for.

Lyrica (pregabalin) is a closely related drug in the same class, prescribed for many of the same reasons and carrying the same off-label pattern. This litigation covers both. Unless we say otherwise, everything on this page about gabapentin eligibility applies equally to Lyrica.

Why Are Gabapentin Lawsuits Being Investigated?

If you or someone you love took gabapentin for months or years and is now living with memory loss, confusion, or a dementia diagnosis that seemed to come out of nowhere, you're probably asking the question a growing number of researchers have started asking too: could the medication be connected? Between 2023 and 2025, a series of large studies looked for an answer. The most-cited, published in 2025 in Regional Anesthesia & Pain Medicine, followed patients with six or more gabapentin prescriptions and found a 29% increased rate of dementia diagnoses and an 85% increased rate of mild cognitive impairment diagnoses within 10 years.

In these large patient populations, people with frequent gabapentin use, especially off-label use, were diagnosed with dementia and mild cognitive impairment at significantly higher rates. That's exactly why attorneys are now investigating whether gabapentin's manufacturers knew about this risk and failed to warn patients and doctors clearly enough.

Signs of Cognitive Decline After Taking Gabapentin

Cognitive decline rarely announces itself. It's more often a family member who notices first: repeating the same question, losing track of a conversation, getting lost somewhere familiar. If you or someone you love has taken gabapentin or Lyrica long-term, here's what's worth paying attention to:

• Trouble with everyday tasks you used to handle easily, or getting lost in places you used to know well
• Needing help with personal hygiene or daily routines, or no longer feeling safe behind the wheel
• Increased confusion, irritability, or mood and personality changes
• Losing track of the day, date, or year
• Forgetting familiar people, important dates, or recent conversations

None of this is a diagnosis, and this page isn't meant to be one. If you're noticing these changes in yourself or a family member, talk to a doctor and make sure it's part of your medical record. That record is exactly what our attorneys would need to review. If a doctor has already diagnosed dementia or mild cognitive impairment and gabapentin or Lyrica is part of the medical history, that's when it's worth talking to us too.